Pub Date : 2025-09-04DOI: 10.1016/j.rec.2025.07.010
Juan Benezet-Mazuecos, Jeff S Healey
{"title":"Key messages on subclinical atrial fibrillation from the ARTESiA and NOAH trials.","authors":"Juan Benezet-Mazuecos, Jeff S Healey","doi":"10.1016/j.rec.2025.07.010","DOIUrl":"10.1016/j.rec.2025.07.010","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-02DOI: 10.1016/j.rec.2025.08.002
Álvaro Rodríguez-Pérez, Carlos Moliner-Abos, David Viladés-Medel, Juan Fernández-Martínez, Josep Mayol-Domingo, Adrián Ruíz-López, Mario Salido, Martín Descalzo, Sandra Pujadas-Olano, Irene Menduiña, Lidia Bos-Real, José A Parada-Barcia, Manuel Barreiro-Pérez, Ilana Forado-Benatar, Andrea Arenas-Loriente, Rubén Leta-Petracca, Dabit Arzamendi, Chi Hion Pedro Li
Introduction and objectives: Hepatic, portal, and intrarenal venous flows are impaired in significant tricuspid regurgitation (TR), but the impact of massive and torrential TR remains unclear. This study assessed these venous flow patterns across the 5-grade TR classification and their potential as grading markers.
Methods: Patients with TR were prospectively included from 3 centers. Exclusion criteria were admission for heart failure, cirrhosis, and stage V renal disease. TR severity was classified using biplane vena contracta width and 2-dimensional effective regurgitant orifice area. Venous flow patterns (hepatic vein reverse systolic flow, portal pulsatility fraction, monophasic intrarenal flow, and reverse portal and intrarenal systolic flows) were analyzed for each TR grade.
Results: Of the 143 patients (52 grade III, 30 grade IV, 17 grade V TR), worsening TR was associated with progressively abnormal venous flow. Hepatic vein reverse flow had high sensitivity (96%) but lower specificity (73%) for grade III TR and was less useful for grades IV-V. Monophasic intrarenal flow had high specificity (97%) for grade III TR. Portal pulsatility fraction worsened with severity, with cutoffs of ≥ 40% for grade III, ≥ 80% for grade IV, and> 100% for grade V. Reverse portal and intrarenal systolic flows were highly specific for grade V (94% and 97%, respectively).
Conclusions: Increasing TR severity correlates with abnormal hepatic, portal, and intrarenal venous flow patterns, which can be assessed through routine echocardiography.
{"title":"Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades.","authors":"Álvaro Rodríguez-Pérez, Carlos Moliner-Abos, David Viladés-Medel, Juan Fernández-Martínez, Josep Mayol-Domingo, Adrián Ruíz-López, Mario Salido, Martín Descalzo, Sandra Pujadas-Olano, Irene Menduiña, Lidia Bos-Real, José A Parada-Barcia, Manuel Barreiro-Pérez, Ilana Forado-Benatar, Andrea Arenas-Loriente, Rubén Leta-Petracca, Dabit Arzamendi, Chi Hion Pedro Li","doi":"10.1016/j.rec.2025.08.002","DOIUrl":"10.1016/j.rec.2025.08.002","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Hepatic, portal, and intrarenal venous flows are impaired in significant tricuspid regurgitation (TR), but the impact of massive and torrential TR remains unclear. This study assessed these venous flow patterns across the 5-grade TR classification and their potential as grading markers.</p><p><strong>Methods: </strong>Patients with TR were prospectively included from 3 centers. Exclusion criteria were admission for heart failure, cirrhosis, and stage V renal disease. TR severity was classified using biplane vena contracta width and 2-dimensional effective regurgitant orifice area. Venous flow patterns (hepatic vein reverse systolic flow, portal pulsatility fraction, monophasic intrarenal flow, and reverse portal and intrarenal systolic flows) were analyzed for each TR grade.</p><p><strong>Results: </strong>Of the 143 patients (52 grade III, 30 grade IV, 17 grade V TR), worsening TR was associated with progressively abnormal venous flow. Hepatic vein reverse flow had high sensitivity (96%) but lower specificity (73%) for grade III TR and was less useful for grades IV-V. Monophasic intrarenal flow had high specificity (97%) for grade III TR. Portal pulsatility fraction worsened with severity, with cutoffs of ≥ 40% for grade III, ≥ 80% for grade IV, and> 100% for grade V. Reverse portal and intrarenal systolic flows were highly specific for grade V (94% and 97%, respectively).</p><p><strong>Conclusions: </strong>Increasing TR severity correlates with abnormal hepatic, portal, and intrarenal venous flow patterns, which can be assessed through routine echocardiography.</p>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145001549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-02DOI: 10.1016/j.rec.2025.06.012
Julia Rey-Brandariz, Carla Guerra-Tort, Ana Teijeiro, Lucía Rodríguez-Loureiro, Mónica Pérez-Ríos
{"title":"Perceptions of the Spanish population regarding various public health measures to control tobacco use.","authors":"Julia Rey-Brandariz, Carla Guerra-Tort, Ana Teijeiro, Lucía Rodríguez-Loureiro, Mónica Pérez-Ríos","doi":"10.1016/j.rec.2025.06.012","DOIUrl":"10.1016/j.rec.2025.06.012","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145001504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.07.008
Alberto Domínguez-Rodríguez , Daniel Hernández-Vaquero , Néstor Baéz-Ferrer
{"title":"The invisible threat: air pollution is now the second leading risk factor for mortality in the general population","authors":"Alberto Domínguez-Rodríguez , Daniel Hernández-Vaquero , Néstor Baéz-Ferrer","doi":"10.1016/j.rec.2025.07.008","DOIUrl":"10.1016/j.rec.2025.07.008","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 128-130"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.05.015
David Calvo
{"title":"Registries of the Heart Rhythm Association of the Spanish Society of Cardiology: current role and future prospects","authors":"David Calvo","doi":"10.1016/j.rec.2025.05.015","DOIUrl":"10.1016/j.rec.2025.05.015","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 12","pages":"Pages 1113-1114"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.07.007
Francisco Javier García-Fernández , Rocío Cózar-León , Josep Navarro-Manchón , Manuel Molina-Lerma , David Calvo , on behalf of the collaborators of the Spanish pacemaker registry
Introduction
This report presents data on cardiac pacing system implants in Spain during 2024.
Methods
The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, CardioDispositivos. Additional data sources included: a) data provided by device manufacturers and distributors, b) the European pacemaker patient card, and c) local databases submitted by implanting centers.
Results
A total of 128 hospitals submitted data to the registry (16 more than in 2023 and 46 more than in 2022). In total, 26 412 units were reported (an 8.5% increase compared with 2023 and 60.8% compared with 2022), vs 47 162 units reported by Eucomed (European Confederation of Medical Suppliers Associations). Among these, 1715 were cardiac resynchronization pacemakers. Leadless pacemaker use continued to rise (1049 devices), accounting for 2.2% of all pacemakers. The most common indication was atrioventricular block, followed by atrial tachyarrhythmia with slow ventricular response. Devices included in remote monitoring also increased: the most notable growth was observed in high-energy resynchronization devices (87%) and leadless pacemakers (38%). Moderate increases were also noted for conventional cardiac resynchronization pacemakers (59%) and standard pacemakers (39%).
Conclusions
Participation in the pacemaker registry continues to grow, reaching 56% of the number of units reported by manufacturers to Eucomed. Remote monitoring maintains the slow but steady growth trend observed in recent years.
{"title":"Spanish pacemaker registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2024)","authors":"Francisco Javier García-Fernández , Rocío Cózar-León , Josep Navarro-Manchón , Manuel Molina-Lerma , David Calvo , on behalf of the collaborators of the Spanish pacemaker registry","doi":"10.1016/j.rec.2025.07.007","DOIUrl":"10.1016/j.rec.2025.07.007","url":null,"abstract":"<div><h3>Introduction</h3><div>This report presents data on cardiac pacing system implants in Spain during 2024.</div></div><div><h3>Methods</h3><div>The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, <em>CardioDispositivos</em>. Additional data sources included: <em>a)</em> data provided by device manufacturers and distributors, <em>b)</em> the European pacemaker patient card, and <em>c)</em> local databases submitted by implanting centers.</div></div><div><h3>Results</h3><div>A total of 128 hospitals submitted data to the registry (16 more than in 2023 and 46 more than in 2022). In total, 26 412 units were reported (an 8.5% increase compared with 2023 and 60.8% compared with 2022), vs 47 162 units reported by Eucomed (European Confederation of Medical Suppliers Associations). Among these, 1715 were cardiac resynchronization pacemakers. Leadless pacemaker use continued to rise (1049 devices), accounting for 2.2% of all pacemakers. The most common indication was atrioventricular block, followed by atrial tachyarrhythmia with slow ventricular response. Devices included in remote monitoring also increased: the most notable growth was observed in high-energy resynchronization devices (87%) and leadless pacemakers (38%). Moderate increases were also noted for conventional cardiac resynchronization pacemakers (59%) and standard pacemakers (39%).</div></div><div><h3>Conclusions</h3><div>Participation in the pacemaker registry continues to grow, reaching 56% of the number of units reported by manufacturers to Eucomed. Remote monitoring maintains the slow but steady growth trend observed in recent years.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 12","pages":"Pages 1076-1087"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-27DOI: 10.1016/j.rec.2025.08.001
Margarida G. Figueiredo, José Miguel Viegas, Sílvia Aguiar Rosa
{"title":"Hypertrophic cardiomyopathy with sequential intracavitary obstruction resolved by mavacamten","authors":"Margarida G. Figueiredo, José Miguel Viegas, Sílvia Aguiar Rosa","doi":"10.1016/j.rec.2025.08.001","DOIUrl":"10.1016/j.rec.2025.08.001","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 187-188"},"PeriodicalIF":4.9,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19DOI: 10.1016/j.rec.2025.06.011
Raquel Campuzano , Julio Núñez , Violeta Sánchez , Juan José Gómez-Doblas , Vicente Arrarte , Ángel Cequier , Blanca Miranda , Cristina Fernández , Náyade Prado , Nicolás Rosillo , José Luis Bernal , Pablo Pérez , Sonia Gutiérrez , Jordi Bañeras
Introduction and objectives
Atherosclerotic vascular disease is the main cause of mortality attributable to air pollution. This study analyzes, for the first time, the association between levels of fine particulate matter (PM2.5, particles ≤ 2.5 μm in diameter) and hospital admissions and in-hospital mortality due to acute myocardial infarction (AMI) in hospitals of the Spanish National Health System.
Methods
Data on air pollution, temperature, and humidity were obtained from the Ministry for the Ecological Transition and the Demographic Challenge, covering the period from 2016 to 2021. A total of 122 National Health System hospitals were geographically matched with environmental monitoring stations located within a 10 km radius. The study included 115 071 patients aged 18 years or older (mean age, 67 years; 28% women) who were discharged with a diagnosis of AMI during the study period. An autoregressive integrated moving average (ARIMA) model was applied to each hospital, and a meta-analysis was conducted to consolidate the estimates of the association between PM2.5 levels and variations in AMI hospital admissions. The association between PM2.5 pollution and in-hospital AMI mortality was analyzed using logistic regression models.
Results
Maximum 3-day average PM2.5 levels exceeding 10 μg/m3 were associated with an additional 21.9 AMI hospital admissions per 1000 (95%CI, 9.1-34.8; P < .001). Furthermore, PM2.5 levels above 25 μg/m3 (3-day moving average) were associated with an increased risk of in-hospital mortality due to AMI (OR, 1.14; 95%CI, 1.07-1.23; P < .001).
Conclusions
This study identifies a significant association between elevated PM2.5 levels and increased hospital admissions and in-hospital mortality due to AMI in Spain, highlighting the importance of reducing air pollution as a critical factor in cardiovascular health.
{"title":"Impact of fine particulate matter (PM2.5) pollution on hospital admissions and mortality due to acute myocardial infarction in Spain","authors":"Raquel Campuzano , Julio Núñez , Violeta Sánchez , Juan José Gómez-Doblas , Vicente Arrarte , Ángel Cequier , Blanca Miranda , Cristina Fernández , Náyade Prado , Nicolás Rosillo , José Luis Bernal , Pablo Pérez , Sonia Gutiérrez , Jordi Bañeras","doi":"10.1016/j.rec.2025.06.011","DOIUrl":"10.1016/j.rec.2025.06.011","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Atherosclerotic vascular disease is the main cause of mortality attributable to air pollution. This study analyzes, for the first time, the association between levels of fine particulate matter (PM<sub>2.5</sub>, particles ≤ 2.5<!--> <!-->μm in diameter) and hospital admissions and in-hospital mortality due to acute myocardial infarction (AMI) in hospitals of the Spanish National Health System.</div></div><div><h3>Methods</h3><div>Data on air pollution, temperature, and humidity were obtained from the Ministry for the Ecological Transition and the Demographic Challenge, covering the period from 2016 to 2021. A total of 122 National Health System hospitals were geographically matched with environmental monitoring stations located within a 10<!--> <!-->km radius. The study included 115 071 patients aged 18 years or older (mean age, 67 years; 28% women) who were discharged with a diagnosis of AMI during the study period. An autoregressive integrated moving average (ARIMA) model was applied to each hospital, and a meta-analysis was conducted to consolidate the estimates of the association between PM<sub>2.5</sub> levels and variations in AMI hospital admissions. The association between PM<sub>2.5</sub> pollution and in-hospital AMI mortality was analyzed using logistic regression models.</div></div><div><h3>Results</h3><div>Maximum 3-day average PM<sub>2.5</sub> levels exceeding 10<!--> <!-->μg/m<sup>3</sup> were associated with an additional 21.9 AMI hospital admissions per 1000 (95%CI, 9.1-34.8; <em>P</em> <!--><<!--> <!-->.001). Furthermore, PM<sub>2.5</sub> levels above 25<!--> <!-->μg/m<sup>3</sup> (3-day moving average) were associated with an increased risk of in-hospital mortality due to AMI (OR, 1.14; 95%CI, 1.07-1.23; <em>P<!--> </em><<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>This study identifies a significant association between elevated PM<sub>2.5</sub> levels and increased hospital admissions and in-hospital mortality due to AMI in Spain, highlighting the importance of reducing air pollution as a critical factor in cardiovascular health.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 117-127"},"PeriodicalIF":4.9,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-14DOI: 10.1016/j.rec.2025.06.010
Rafael de la Espriella
{"title":"Refractory congestion in heart failure: when standard therapies fall short","authors":"Rafael de la Espriella","doi":"10.1016/j.rec.2025.06.010","DOIUrl":"10.1016/j.rec.2025.06.010","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 11","pages":"Pages 1007-1009"},"PeriodicalIF":4.9,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号